Keyphrases
Transcatheter Aortic Valve Replacement
52%
Transcatheter Aortic Valve Implantation
44%
ST-elevation Myocardial Infarction (STEMI)
35%
Severe Aortic Stenosis
26%
Hypoxia-inducible factor-1α (HIF-1α)
23%
Cardiorenal Syndrome
19%
Chronic Kidney Disease
18%
Prognostic Implications
17%
Coronary Microvascular Dysfunction
17%
Myocardial Infarction
16%
Clinical Outcomes
15%
Endothelial Progenitor Cells
15%
Angiogenesis
13%
Rat Model
13%
Percutaneous Coronary Intervention
13%
Aortic Stenosis
13%
Long-term Survival
12%
Angiogenic
12%
Single-center Study
12%
Vasculogenesis
12%
Myocardial Infarction Patients
11%
Chronic Volume Overload
11%
Cardiac Remodeling
11%
Erythropoietin
11%
Matrix metalloproteinase-9 (MMP-9)
11%
Islet1
11%
Blocking Antibodies
11%
Transcatheter Heart Valve
11%
Coronary Microvascular Disease
11%
Primary Percutaneous Coronary Intervention
11%
Paravalvular Leak
11%
Clinical Presentation
10%
Confidence Interval
10%
Endothelial Cells
10%
Coronary Angiography
9%
Device Success
9%
Long-term Mortality
9%
Consecutive Patients
9%
Cardiac Function
9%
Pacemaker
8%
Hazard Ratio
8%
Regulatory T (Treg) Cells
8%
Edwards SAPIEN
8%
Cardiac Hypertrophy
8%
Overexpression
8%
Drug-eluting Stent
8%
Echocardiography
8%
Patient Selection
8%
Cardiac Cells
8%
Acute Myocardial Infarction
8%
Medicine and Dentistry
Percutaneous Aortic Valve Replacement
100%
Aortic Stenosis
33%
ST Segment Elevation Myocardial Infarction
24%
Myocardial Infarction
21%
Aortic Valve
20%
Cardiorenal Syndrome
19%
Chronic Kidney Disease
17%
Coronary Microvascular Dysfunction
17%
Percutaneous Coronary Intervention
15%
Long Term Survival
12%
Congestive Heart Failure
12%
Primary Percutaneous Coronary Intervention
12%
Endothelial Progenitor Cell
11%
Angiogenesis
11%
Microangiopathy
11%
Pacemaker Implantation
11%
Paravalvular Leak
11%
Aortic Valve Prosthesis
10%
Cardiovascular Disease
10%
Prevalence
9%
Coronary Angiography
9%
Coronary Artery Disease
9%
Heart Function
9%
Heart Left Ventricle Function
9%
Drug-Eluting Stent
8%
Echocardiography
8%
Cardiac Fibrosis
7%
Endothelial Cell
7%
Heart Left Ventricle Ejection Fraction
7%
Ejection Fraction
7%
Stent Thrombosis
7%
Hemodynamic
6%
Gene Targeting
6%
Hazard Ratio
6%
Acute Kidney Injury
6%
Comorbidity
6%
Infective Endocarditis
5%
Mitral Valve Repair
5%
Fluid Balance
5%
Neutrophil Gelatinase Associated Lipocalin
5%
Carotid Artery Stenosis
5%
Balloon Dilatation
5%
Heart Ventricle Remodeling
5%
Gelatinase B
5%
Ventricular Hypertrophy
5%
Mitral Valve
5%
Anesthesiologist
5%
Lipoprotein
5%
Respiratory Disease
5%
Downregulation
5%
